The Double-Icodextrin Dose Randomized Controlled Trial of a Double Icodextrin Dose for Older Patients on Incremental Continuous Ambulatory Peritoneal Dialysis | Synapse
March 3, 2026Open Access
The Double-Icodextrin Dose Randomized Controlled Trial of a Double Icodextrin Dose for Older Patients on Incremental Continuous Ambulatory Peritoneal Dialysis
Key Points
The double icodextrin dose improves fluid balance in older patients undergoing dialysis, enhancing treatment outcomes.
Participants receiving the double dose showed greater fluid management capabilities, with efficiencies observed during the study period.
Randomized controlled trial design employed to rigorously test dosing strategies among older patients on dialysis.
The findings highlight the need for personalized dosing in older patients to improve their overall health outcomes.